Fecal microbiota transplantation (FMT) is considered an investigational new drug (IND), which typically requires an application to be filed; however, the FDA has released specific guidance related to these types of therapies.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: February 1, 2017
Dzintars, Kathryn. "OpenBiome." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540673/all/OpenBiome.
Dzintars K. OpenBiome. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540673/all/OpenBiome. Accessed June 9, 2023.
Dzintars, K. (2017). OpenBiome. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540673/all/OpenBiome
Dzintars K. OpenBiome [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2023 June 09]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540673/all/OpenBiome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - OpenBiome ID - 540673 A1 - Dzintars,Kathryn,PharmD, BCPS Y1 - 2017/02/01/ BT - Johns Hopkins ABX Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540673/all/OpenBiome PB - The Johns Hopkins University DB - Johns Hopkins Guides DP - Unbound Medicine ER -